Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5737537 | Neuroscience | 2017 | 12 Pages |
Abstract
GM1 gangliosides (GM1) are acidic glycosphingolipids that are present in cell membranes and lipid raft domains, being particularly abundant in central nervous systems. GM1 participate in modulating cell membrane properties, intercellular recognition, cell regulation, and signaling. We previously demonstrated that GM1 are expressed inside astrocytes but not on the cell surface. We investigated whether the antipsychotic drug haloperidol induces GM1 expression in astrocytes, and found that the expression of GM1 was significantly upregulated by haloperidol in the intracellular vesicles of cultured astrocytes. The effects of haloperidol on GM1 expression acted through the Ï1 receptor (Ï1R), but not the dopamine-2 receptor. Inhibition of the ERK pathway blocked the induction of GM1 through the Ï1R by haloperidol. Interestingly, this increase in GM1 expression induced the accumulation of autophagosomes in astrocytes. Moreover, the effect of haloperidol on the Ï1R induced a decrease in GM1 in the cellular membrane of astrocytes. These findings suggested that the effects of haloperidol on the Ï1R induced GM1 accumulation in the autophagosomes of astrocytes through activating the ERK pathway and a decrease in GM1 expression on the cell surface.
Keywords
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Rika Kasahara, Naoki Yamamoto, Kenji Suzuki, Kazuya Sobue,